Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has issued an announcement.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, has announced an update on its 6th proposed share repurchase. The board confirms the accuracy of the information provided and mentions several past announcements related to the resolutions passed during the financial year 2019, the proposed adoption of the 2019 Restricted A-Share Incentive Scheme, and adjustments to the List of Participants for the Initial Grant.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
YTD Price Performance: -0.05%
Average Trading Volume: 566
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €3.45B
Learn more about 2TZ stock on TipRanks’ Stock Analysis page.
